0.00Open0.30Pre Close0 Volume2 Open Interest15.00Strike Price0.00Turnover69.96%IV11.71%PremiumSep 20, 2024Expiry Date0.00Intrinsic Value100Multiplier16DDays to Expiry0.30Extrinsic Value100Contract SizeAmericanOptions Type-0.2018Delta0.1139Gamma55.50Leverage Ratio-0.0211Theta-0.0015Rho-11.20Eff Leverage0.0099Vega
Afya Ltd Stock Discussion
• $Afya Ltd (AFYA.US)$: Credit Suisse Upgrades to Outperform from Neutral - PT $19 (from $18)
• $Appfolio (APPF.US)$: KeyBanc Upgrades to Overweight from Sector Weight - PT $143
• $C.H. Robinson Worldwide (CHRW.US)$: JPMorgan Upgrades to Overweight from Neutral - PT $117 (from $91)
• $Coupang (CPNG.US)$: Goldman Sachs Upgrades to Conviction Buy from Buy - PT $37
• $Gatos Silver (GATO.US)$: RBC Capital Upgrades to Sector Perform from Underperform - PT $4
• $ITT Inc (ITT.US)$: UBS Upgr...
• $Array Technologies (ARRY.US)$ +12.87% (also names new CEO)
• $Tufin Software Technologies (TUFN.US)$ +43.41% (enters into definitive agreement to be acquired by Turn/River Capital in a $570 million transaction; TUFN shareholders will receive $13.00/share in cash)
• $Citius Pharmaceuticals (CTXR.US)$ +10.87% (reported topline results from the pivotal Phase 3 trial of I/ONTAK)
• $BioXcel Therapeutics (BTAI.US)$ +19.22% (FDA ha...
No comment yet